[ALLIANZ] QoQ Annualized Quarter Result on 30-Sep-2015 [#3]

Stock
[ALLIANZ] ALLIANZ MALAYSIA BHD
Announcement Date
20-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 2.99%
YoY- -1.0%
Quarter Report
Latest QR
Upcoming QR
ALLIANZ's Result
ALLIANZ's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 4,631,478 4,669,172 4,519,497 4,465,392 4,427,220 4,399,960 4,376,184 3.85%
PBT 448,632 459,988 438,221 414,961 427,712 449,676 423,530 3.91%
Tax -149,696 -167,272 -129,350 -118,152 -139,514 -155,112 -127,628 11.22%
NP 298,936 292,716 308,871 296,809 288,198 294,564 295,902 0.68%
-
NP to SH 298,936 292,716 308,871 296,809 288,198 294,564 295,902 0.68%
-
Tax Rate 33.37% 36.36% 29.52% 28.47% 32.62% 34.49% 30.13% -
Total Cost 4,332,542 4,376,456 4,210,626 4,168,582 4,139,022 4,105,396 4,080,282 4.08%
-
Net Worth 2,721,144 2,710,772 2,611,603 2,504,117 2,438,365 2,378,602 2,266,222 12.98%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div - - 10,966 - - - 8,289 -
Div Payout % - - 3.55% - - - 2.80% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 2,721,144 2,710,772 2,611,603 2,504,117 2,438,365 2,378,602 2,266,222 12.98%
NOSH 169,541 169,317 168,708 168,513 168,163 167,861 165,780 1.50%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 6.45% 6.27% 6.83% 6.65% 6.51% 6.69% 6.76% -
ROE 10.99% 10.80% 11.83% 11.85% 11.82% 12.38% 13.06% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 2,731.76 2,757.64 2,678.88 2,649.86 2,632.69 2,621.18 2,639.74 2.31%
EPS 176.32 172.88 183.08 176.13 171.38 175.48 178.49 -0.81%
DPS 0.00 0.00 6.50 0.00 0.00 0.00 5.00 -
NAPS 16.05 16.01 15.48 14.86 14.50 14.17 13.67 11.30%
Adjusted Per Share Value based on latest NOSH - 167,501
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 2,579.22 2,600.21 2,516.85 2,486.72 2,465.47 2,450.29 2,437.05 3.85%
EPS 166.47 163.01 172.01 165.29 160.49 164.04 164.78 0.68%
DPS 0.00 0.00 6.11 0.00 0.00 0.00 4.62 -
NAPS 15.1537 15.096 14.5437 13.9451 13.579 13.2462 12.6203 12.98%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 10.06 10.72 10.50 10.60 11.78 12.54 11.42 -
P/RPS 0.37 0.39 0.39 0.40 0.45 0.48 0.43 -9.54%
P/EPS 5.71 6.20 5.74 6.02 6.87 7.15 6.40 -7.32%
EY 17.53 16.13 17.44 16.62 14.55 13.99 15.63 7.95%
DY 0.00 0.00 0.62 0.00 0.00 0.00 0.44 -
P/NAPS 0.63 0.67 0.68 0.71 0.81 0.88 0.84 -17.46%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 18/08/16 27/05/16 26/02/16 20/11/15 26/08/15 27/05/15 27/02/15 -
Price 10.22 9.92 9.93 10.52 10.18 12.80 12.30 -
P/RPS 0.37 0.36 0.37 0.40 0.39 0.49 0.47 -14.75%
P/EPS 5.80 5.74 5.42 5.97 5.94 7.29 6.89 -10.85%
EY 17.25 17.43 18.44 16.74 16.83 13.71 14.51 12.23%
DY 0.00 0.00 0.65 0.00 0.00 0.00 0.41 -
P/NAPS 0.64 0.62 0.64 0.71 0.70 0.90 0.90 -20.34%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment